Stay updated on Talquetamab Pre-Approval Access in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T05:56:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the pre-approval access program for talquetamab in treating relapsed or refractory multiple myeloma, including detailed descriptions of the drug, its mechanism, and eligibility criteria. The version number has been updated from v2.14.4 to v2.15.0.
    Difference
    22%
    Check dated 2025-04-16T15:03:39.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The webpage has removed all location data related to a study that previously included seven countries, and it has updated the revision number from v2.14.3 to v2.14.4.
    Difference
    6%
    Check dated 2025-04-09T10:38:44.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    3%
    Check dated 2025-02-24T22:29:10.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-10T15:07:59.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.2%
    Check dated 2025-02-03T10:35:08.000Z thumbnail image

Stay in the know with updates to Talquetamab Pre-Approval Access in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talquetamab Pre-Approval Access in Myeloma Clinical Trial page.